Cognitive and psychiatric phenotypes of movement disorders in children: A systematic review

Developmental Medicine and Child Neurology

Volumn 53, Issue 12, 2011, Pages 1077-1084

  Ben Pazi, Hilla ^a   Jaworowski, Solomon ^a   Shalev, Ruth S ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOPAMINE RECEPTOR STIMULATING AGENT; IRON; LEVODOPA;

ADULT; ATTENTION; ATTENTION DEFICIT DISORDER; AUTISM; AUTOIMMUNE DISEASE; AUTOMUTILATION; BIPOLAR DISORDER; BRAIN DYSFUNCTION; CERVICAL DYSTONIA; CHILD; CHILDHOOD DISEASE; CHOREA MINOR; COGNITIVE DEFECT; CRIME; DEFENSE MECHANISM; DEPRESSION; DISEASE ASSOCIATION; DYSPHORIA; DYSTONIA; EXECUTIVE FUNCTION; FRONTAL LOBE; GENERALIZED ANXIETY DISORDER; GENERALIZED DYSTONIA; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; HYPERACTIVITY; IDIOPATHIC DISEASE; INTELLIGENCE QUOTIENT; IRRITABILITY; KUGELBERG WELANDER DISEASE; LANGUAGE DISABILITY; MEMORY DISORDER; MENTAL DISEASE; MENTAL INSTABILITY; MOTOR DYSFUNCTION; MYOCLONUS DYSTONIA; OBSESSIVE COMPULSIVE DISORDER; OPPOSITIONAL DEFIANT DISORDER; OPSOCLONUS MYOCLONUS SYNDROME; PARKINSONISM; PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTION; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PRIORITY JOURNAL; PSYCHOGENIC MOVEMENT DISORDER; PSYCHOSIS; RESTLESS LEGS SYNDROME; REVIEW; SCHIZOPHRENIA; SEGAWA SYNDROME; SEPARATION ANXIETY; SPEECH ARTICULATION; STEREOTYPY; STREPTOCOCCUS INFECTION; SYSTEMATIC REVIEW; TORSION DYSTONIA; VERBAL BEHAVIOR; WILSON DISEASE; WORKING MEMORY; WRITER'S CRAMP;

CHILD, PRESCHOOL; COMORBIDITY; HUMANS; MOVEMENT DISORDERS; PHENOTYPE;

EID: 81355148687     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.04134.x     Document Type: Review

References (86)

1. Negre-Pages L, Grandjean H, Lapeyre-Mestre M, et al. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Mov Disord 2010; 25: 157-66.
2. Louis ED. Essential tremor as a neuropsychiatric disorder. J Neurol Sci 2010; 289: 144-8.
3. Pappa S, Dazzan P. Spontaneous movement disorders in antipsychotic-naive individuals with first-episode psychoses: a systematic review. Psychol Med 2009; 39: 1065-76.
4. Boyle PA, Wilson RS, Aggarwal NT, et al. Parkinsonian signs in subjects with mild cognitive impairment. Neurology 2005; 65: 1901-6.
5. Sanger TD, Chen D, Fehlings DL, et al. Definitions and classification of hyperkinetic movement disorders in childhood. Mov Disord 2010; 25: 1538-49.
6. Zomorrodi A, Wald ER. Sydenham chorea in western Pennsylvania. Pediatrics 2006; 117: e675-9.
7. Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 1993; 91: 706-13.
8. Maia DP, Teixeira AL Jr, Quintao Cunningham MC, Cardoso F. Obsessive compulsive behaviour, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology 2005; 64: 1799-801.
9. de Alvarenga PG, Floresi AC, Torres AR, et al. Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever. Gen Hosp Psychiatry 2009; 31: 178-80.
10. Asbahr FR, Negrao AB, Gentil V, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998; 155: 1122-4.
11. Hounie AG, Pauls DL, Mercadante MT, et al. Obsessive-compulsive spectrum disorders in rheumatic fever with and without Sydenham chorea. J Clin Psychiatry 2004; 65: 994-9.
12. Hounie AG, Pauls DL, do Rosario-Campos MC, et al. Obsessive-compulsive spectrum disorders and rheumatic fever: a family study. Biol Psychiatry 2007; 61: 266-72.
13. Asbahr FR, Garvey MA, Snider LA, et al. Obsessive-compulsive symptoms among individuals with Sydenham chorea. Biol Psychiatry 2005; 57: 1073-6.
14. Ridel KR, Lipps TD, Gilbert DL. The prevalence of neuropsychiatric disorders in Sydenham chorea. Pediatr Neurol 2010; 42: 243-8.
15. Teixeira AL, Athayde GR, Sacramento DR, Maia DP, Cardoso F. Depressive and anxiety symptoms in Sydenham chorea. Mov Disord 2007; 22: 905-6.
16. Seixas AA, Hounie AG, Fossaluza V, et al. Anxiety disorders and rheumatic fever: is there an association? CNS Spectr 2008; 13: 1039-46.
17. Teixeira AL Jr, Maia DP, Cardoso F. Psychosis following acute Sydenham chorea. Eur Child Adolesc Psychiatry 2007; 16: 67-9.
18. Wilcox JA, Nasrallah HA. Sydenham chorea and psychosis. Neuropsychobiology 1986; 15: 13-4.
19. Wilcox JA, Nasrallah H. Sydenham chorea and psychopathology. Neuropsychobiology 1988; 19: 6-8.
20. Cunningham MC, Maia DP, Teixeira AL Jr, Cardoso F. Sydenham chorea is associated with decreased verbal fluency. Parkinsonism Relat Disord 2006; 12: 165-7.
21. Cavalcanti A, Hilario MO, dos Santos FH, et al. Subtle cognitive deficits in adults with a previous history of Sydenham chorea during childhood. Arthritis Care Res (Hoboken) 2010; 62: 1065-71.
22. Bird TD, Carlson CB, Hall JG. Familial essential ('benign') chorea. J Med Genet 1976; 13: 357-62.
23. Schrag A, Quinn NP, Bhatia KP, Marsden CD. Benign hereditary chorea - entity or syndrome? Mov Disord 2000; 15: 280-8.
24. Kleiner-Fisman G, Lang AE. Benign hereditary chorea revisited: a journey to understanding. Mov Disord 2007; 22: 2297-305, quiz 452.
25. Hammer MS, Larsen MB, Stack CV. Outcome of children with opsoclonus-myoclonus regardless of aetiology. Pediatr Neurol 1995; 13: 21-4.
26. Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA. Long-term neurological outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Paediatric Oncology Group. Med Pediatr Oncol 1997; 28: 284-8.
27. Koh PS, Raffensperger JG, Berry S, et al. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr 1994; 125: 712-6.
28. Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ. Neuroepidemiologic trends in 105 US cases of paediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs 2005; 22: 8-19.
29. Hayward K, Jeremy RJ, Jenkins S, et al. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. J Pediatr 2001; 139: 552-9.
30. Papero PH, Pranzatelli MR, Margolis LJ, et al. Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome. Dev Med Child Neurol 1995; 37: 915-32.
31. Turkel SB, Brumm VL, Mitchell WG, Tavare CJ. Mood and behavioural dysfunction with opsoclonus-myoclonus ataxia. J Neuropsychiatry Clin Neurosci 2006; 18: 239-41.
32. Klein A, Schmitt B, Boltshauser E. Long-term outcome of ten children with opsoclonus-myoclonus syndrome. Eur J Pediatr 2007; 166: 359-63.
33. De Grandis E, Parodi S, Conte M, et al. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics 2009; 40: 103-11.
34. Ghanizadeh A, Mosallaei S. Psychiatric disorders and behavioural problems in children and adolescents with Tourette syndrome. Brain Dev 2009; 31: 15-9.
35. Burd L, Li Q, Kerbeshian J, Klug MG, Freeman RD. Tourette syndrome and comorbid pervasive developmental disorders. J Child Neurol 2009; 24: 170-5.
36. Robertson MM. Mood disorders and Gilles de la Tourette's syndrome: an update on prevalence, aetiology, comorbidity, clinical associations, and implications. J Psychosom Res 2006; 61: 349-58.
37. Miguel EC, Baer L, Coffey BJ, et al. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry 1997; 170: 140-5.
38. Burd L, Freeman RD, Klug MG, Kerbeshian J. Tourette syndrome and learning disabilities. BMC Pediatr 2005; 5: 34.
39. Denckla MB. Attention deficit hyperactivity disorder: the childhood co-morbidity that most influences the disability burden in Tourette syndrome. Adv Neurol 2006; 99: 17-21.
40. Denckla MB. Attention Deficit Hyperactivity Disorder: the Childhood Comorbidity That Most Influences Tourette Syndrome's Disability Burden. Philadelphia, PA: Lippincott, Williams and Wilkins, 2006.
41. Kurlan R, Como PG, Miller B, et al. The behavioural spectrum of tic disorders: a community-based study. Neurology 2002; 59: 414-20.
42. Roessner V, Becker A, Banaschewski T, Rothenberger A. Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects. J Abnorm Child Psychol 2007; 35: 79-85.
43. Dale RC, Heyman I, Surtees RA, et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 2004; 89: 604-10.
44. Swedo SE, Leonard HL, Garvey M, et al. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264-71.
45. Mink JW, Zinner SH. Movement disorders ii: chorea, dystonia, myoclonus, and tremor. Pediatr Rev 2010; 31: 287-94, quiz 95.
46. Harris KM, Mahone EM, Singer HS. Nonautistic motor stereotypies: clinical features and longitudinal follow-up. Pediatr Neurol 2008; 38: 267-72.
47. Mahone EM, Bridges D, Prahme C, Singer HS. Repetitive arm and hand movements (complex motor stereotypies) in children. J Pediatr 2004; 145: 391-5.
48. Tan A, Salgado M, Fahn S. The characterization and outcome of stereotypical movements in nonautistic children. Mov Disord 1997; 12: 47-52.
49. MacDonald R, Green G, Mansfield R, et al. Stereotypy in young children with autism and typically developing children. Res Dev Disabil 2007; 28: 266-77.
50. Goldman S, Wang C, Salgado MW, et al. Motor stereotypies in children with autism and other developmental disorders. Dev Med Child Neurol 2009; 51: 30-8.
51. Chervin RD, Archbold KH, Dillon JE, et al. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep 2002; 25: 213-8.
52. Picchietti DL, Stevens HE. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2008; 9: 770-81.
53. Konofal E, Lecendreux M, Deron J, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 2008; 38: 20-6.
54. Walters AS, Mandelbaum DE, Lewin DS, et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatr Neurol 2000; 22: 182-6.
55. Koukouni V, Martino D, Arabia G, Quinn NP, Bhatia KP. The entity of young onset primary cervical dystonia. Mov Disord 2007; 22: 843-7.
56. Heiman GA, Ottman R, Saunders-Pullman RJ, et al. Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology 2004; 63: 631-7.
57. Hoffmann GF, Assmann B, Bräutigam C, et al. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 2003; 54(Suppl. 6): S56-65.
58. Hahn H, Trant MR, Brownstein MJ, et al. Neurological and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene. Arch Neurol 2001; 58: 749-55.
59. Doheny DO, Brin MF, Morrison CE, et al. Phenotypic features of myoclonus-dystoniain three kindreds. Neurology 2002; 59: 1187-96.
60. Marechal L, Raux G, Dumanchin C, et al. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet B Neuropsychiatr Genet 2003; 119B: 114-7.
61. Saunders-Pullman R, Shriberg J, Heiman G, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002; 58: 242-5.
62. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003; 111: e89-97.
63. Machado A, Chien HF, Deguti MM, et al. Neurological manifestations in Wilson's disease: report of 119 cases. Mov Disord 2006; 21: 2192-6.
64. Lin JJ, Lin KL, Wang HS, Wong MC. Psychological presentations without hepatic involvement in Wilson disease. Pediatr Neurol 2006; 35: 284-6.
65. Gronlund J, Nanto-Salonen K, Venetoklis J, et al. Poor cognitive development and abdominal pain: Wilson's disease. Scand J Gastroenterol 2006; 41: 361-4.
66. Dening TR, Berrios GE. Wilson's disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989; 46: 1126-34.
67. Akil M, Brewer GJ. Psychiatric and behavioural abnormalities in Wilson's disease. Adv Neurol 1995; 65: 171-8.
68. Shanmugiah A, Sinha S, Taly AB, et al. Psychiatric manifestations in Wilson's disease: a cross-sectional analysis. J Neuropsychiatry Clin Neurosci 2008; 20: 81-5.
69. Srinivas K, Sinha S, Taly AB, et al. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge! J Neurol Sci 2008; 266: 104-8.
70. Oder W, Prayer L, Grimm G, et al. Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology 1993; 43: 120-4.
71. Ullah M, Samuel M, Taylor R, Dhawan A, Hedderly T. Survey of presentation and natural history of Wilson's disease in childhood. Paper presented at the 13th International Congress of Parkinson disease and Movement Disorders; 11 June 2009; Paris, France.
72. Gonzalez-Alegre P, Afifi AK. Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 individuals and review of the literature. J Child Neurol 2006; 21: 223-9.
73. Ribai P, Nguyen K, Hahn-Barma V, et al. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 individuals. Arch Neurol 2007; 64: 813-9.
74. Wojaczynska-Stanek K, Adamek D, Marszal E, Hoffman-Zacharska D. Huntington disease in a 9-year-old boy: clinical course and neuropathologic examination. J Child Neurol 2006; 21: 1068-73.
75. Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson disease revisited - clinical features, natural history, and mortality. Mov Disord 1998; 13: 885-94.
76. Ishikawa A, Tsuji S. Clinical analysis of 17 individuals in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996; 47: 160-6.
77. Yamamura Y, Hattori N, Matsumine H, Kuzuhara S, Mizuno Y. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification. Brain Dev 2000; 22(Suppl. 1): S87-91.
78. Muthane UB, Swamy HS, Satishchandra P, et al. Early onset Parkinson disease: are juvenile- and young-onset different? Mov Disord 1994; 9: 539-44.
79. Schwingenschuh P, Pont-Sunyer C, Surtees R, Edwards MJ, Bhatia KP. Psychogenic movement disorders in children: a report of 15 cases and a review of the literature. Mov Disord 2008; 23: 1882-8.
80. Ferrara J, Jankovic J. Psychogenic movement disorders in children. Mov Disord 2008; 23: 1875-81.
81. Kirsch DB, Mink JW. Psychogenic movement disorders in children. Pediatr Neurol 2004; 30: 1-6.
82. Dale RC, Singh H, Troedson C, et al. A prospective study of acute movement disorders in children. Dev Med Child Neurol 2010; 52: 739-48.
83. Sevim S, Dogu O, Kaleagasi H, et al. Correlation of anxiety and depression symptoms in individuals with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004; 75: 226-30.
84. Haber SN. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003; 26: 317-30.
85. Haugbol S, Pinborg LH, Regeur L, et al. Cerebral 5-HT2A receptor binding is increased in individuals with Tourette's syndrome. Int J Neuropsychopharmacol 2007; 10: 245-52.
86. Naumann M, Gotz M, Reiners K, Lange KW, Riederer P. Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism. J Neural Transm 1996; 103: 1083-91.